Analysis Metabolite Name Measured Value Units Exercise Group Sex Type
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-1656Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-1946Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-1957Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-2138Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-2159Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-2424Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-2709Peak area normalizedYes Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-2839Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-2923Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-3059Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-3097Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-3108Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-3287Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-3300Peak area normalizedNo Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-3370Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-3533Peak area normalizedYes PAH Male Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-3685Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-3711Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-3738Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-3748Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-3998Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-4250Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-4265Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-4323Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-4413Peak area normalizedNo Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-4687Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-4765Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-4780Peak area normalizedNo PAH Male Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-4853Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-4893Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-4947Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-4993Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-5106Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-5119Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-5383Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-5594Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-5598Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-5775Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-5833Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-6065Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-6168Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-6401Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-6458Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-6751Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-7054Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-7314Peak area normalizedNo Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-7371Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-9337Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-12393Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedNo Borderline Pressures Male Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedNo Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedNo LowRisk Male Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedNo Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedNo Normal Pressures Male Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedNo PAH Male Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedYes Borderline Pressures Male Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedYes Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedYes LowRisk Male Non-invasive
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedYes Normal Pressures Male Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODECITRULLINE (M-H)-Peak area normalizedYes PAH Male Cath

Return to search page
  logo